Browsing Tag
USFDA
34 posts
Alembic Pharmaceuticals wins big with FDA approval for new allergy eye drops
In a major development that could impact the over-the-counter pharmaceutical market, Alembic Pharmaceuticals Limited has received final approval…
October 3, 2024
Zydus Lifesciences bags FDA tentative approval for Enzalutamide Tablets for prostate cancer treatment
Zydus Lifesciences Limited has secured tentative approval from the United States Food and Drug Administration (USFDA) for its…
October 2, 2024
Dr. Reddy’s joins forces with Gilead Sciences to launch HIV drug Lenacapavir in India and 120 countries
In a historic development for HIV treatment worldwide, Dr. Reddy’s Laboratories has announced a new partnership with Gilead…
October 2, 2024
Biocon faces regulatory heat as USFDA flags critical issues at its Bengaluru facility
In a significant development that has sent shockwaves through the biotechnology industry, Biocon Ltd. has come under fire…
September 30, 2024
Zydus Lifesciences launches fight against prostate cancer with new FDA-approved drug enzalutamide
Zydus Lifesciences Limited has achieved a significant milestone in the pharmaceutical industry. The company recently received final approval…
September 29, 2024
Alembic Pharmaceuticals secures USFDA approval for new Paliperidone extended-release tablets
Alembic Pharmaceuticals Limited has achieved a major milestone in the pharmaceutical industry. On September 27, 2024, the company…
September 28, 2024
Indoco Remedies scores major FDA win with exclusive approval for Lofexidine Tablets
Indoco Remedies Limited has achieved a pivotal milestone with the final approval from the U.S. Food and Drug…
August 21, 2024
Aurobindo Pharma shatters expectations with record-breaking Q1 FY25 earnings
Aurobindo Pharma Limited, a key player in the global pharmaceuticals market, has once again demonstrated remarkable financial health…
August 10, 2024
Zydus Lifesciences gets FDA green light for acne treatment gel
Zydus Lifesciences Limited has secured final approval from the United States Food and Drug Administration (USFDA) for its…
September 20, 2023
Granules India subsidiary completes FDA PADE inspection with zero observations
Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary of Granules India Limited, situated in Chantilly, Virginia, USA,…
August 4, 2023